An Exciting Time For Car T-Cell Therapy: Promising Results For B-All, Nhl And Cll

An exciting time for CAR T-cell therapy: promising results for B-ALL, nHL and CLL

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-cell update: what’s new in DLBCL and MM?

VJHemOnc – Video Journal of Hematology & HemOnc

CAR-T Cell Therapies for CLL: How are the various techniques different?

Real-world data on CAR-T therapy for B-ALL

VJHemOnc – Video Journal of Hematology & HemOnc

Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with NHL and CLL

Research To Practice

CAR-T therapy vs BTK inhibitors in CLL treatment

VJHemOnc – Video Journal of Hematology & HemOnc

CAR-T as a next-generation therapy for CLL

VJHemOnc – Video Journal of Hematology & HemOnc

CAR-T Cell Therapy: Current Uses and Future Possibilities

CAR-T Cell Therapies in CLL

CAR T Cells Impact the Treatment Landscape Across Hematologic Malignancies

Targeted Oncology

Updated safety & durability results for CAR-T lisocabtagene maraleucel in NHL

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T Cells in B-Cell Lymphoma: Implications of New Data and New Therapy

CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine

Morning Medical Update: CAR-T Cell Therapy

The University of Kansas Health System

The 1st iwCAR-T Meeting: facilitating shared knowledge on CAR T-cell therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Weirda Discusses Use of CAR T Cells in CLL

CAR-T Cell Therapy for Leukemia and Lymphoma: Exploring Modern Cellular Therapies

PeerView Oncology

Patient Selection for CAR-T Therapy in NHL

Improving treatment outcomes of CAR T-cell therapy

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-cells in lymphoma: where are we now?

VJHemOnc – Video Journal of Hematology & HemOnc